Literature DB >> 19731578

Comparison of objective and patient-reported hot flash measures in men with prostate cancer.

Laura J Hanisch1, Steven C Palmer, Steven C Marcus, Liisa Hantsoo, David J Vaughn, James C Coyne.   

Abstract

Hot flashes are one of the bothersome symptoms frequently experienced after endocrine treatments for breast and prostate cancers. Many studies have evaluated interventions for hot flashes, but results are obscured by methodologic limitations. We compared the performance of three techniques to measure hot flashes over 48 hours among 47 patients with prostate cancer undergoing androgen deprivation therapy to determine the feasibility and accuracy of each measure. Sternal skin conductance, electronic event marking, and twice daily diaries identified 478, 410, and 285 hot flashes, respectively. Diaries produced the lowest hourly hot flash rate (M = 0.17), which was significantly different from the rates of the objective profile (M = 0.28) and event marks (M = 0.23).The sensitivity and positive predictive value of the three measures demonstrated that the diaries underperformed, but these values did not exceed moderate levels for any measure (% = 28-59). Study results suggest the combined use of sternal skin conductance and event marking for the measurement of hot flash frequency in pathophysiologic studies and clinical trials with prostate cancer patients. Conversely, the use of retrospective diaries may be adequate for clinical practice to determine clinically significant changes in salient events.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19731578

Source DB:  PubMed          Journal:  J Support Oncol        ISSN: 1544-6794


  10 in total

1.  Can alternative medicine do better than placebo?: Does it even matter?

Authors:  Mark A Moyad
Journal:  Can Urol Assoc J       Date:  2010-02       Impact factor: 1.862

2.  Predictors of the trajectories of self-reported sleep disturbance in men with prostate cancer during and following radiation therapy.

Authors:  Christine Miaskowski; Steven M Paul; Bruce A Cooper; Kathryn Lee; Marylin Dodd; Claudia West; Bradley E Aouizerat; Laura Dunn; Patrick S Swift; William Wara
Journal:  Sleep       Date:  2011-02-01       Impact factor: 5.849

3.  Effects of Testosterone and Estradiol Deficiency on Vasomotor Symptoms in Hypogonadal Men.

Authors:  Alexander P Taylor; Hang Lee; Matthew L Webb; Hadine Joffe; Joel S Finkelstein
Journal:  J Clin Endocrinol Metab       Date:  2016-06-14       Impact factor: 5.958

4.  Course and Moderators of Hot Flash Interference during Androgen Deprivation Therapy for Prostate Cancer: A Matched Comparison.

Authors:  Brian D Gonzalez; Heather S L Jim; Kristine A Donovan; Brent J Small; Steve K Sutton; Jong Park; Hui-Yi Lin; Philippe E Spiess; Mayer N Fishman; Paul B Jacobsen
Journal:  J Urol       Date:  2015-03-16       Impact factor: 7.450

5.  Sleep and daily functioning during androgen deprivation therapy for prostate cancer.

Authors:  L J Hanisch; N S Gooneratne; K Soin; P R Gehrman; D J Vaughn; J C Coyne
Journal:  Eur J Cancer Care (Engl)       Date:  2010-09-06       Impact factor: 2.520

Review 6.  Startling Differences: Using the Acoustic Startle Response to Study Sex Differences and Neurosteroids in Affective Disorders.

Authors:  Liisa Hantsoo; Carla E M Golden; Sara Kornfield; Christian Grillon; C Neill Epperson
Journal:  Curr Psychiatry Rep       Date:  2018-05-18       Impact factor: 5.285

7.  Hypothalamic orexin's role in exacerbated cutaneous vasodilation responses to an anxiogenic stimulus in a surgical menopause model.

Authors:  Lauren M Federici; Izabela Facco Caliman; Andrei I Molosh; Stephanie D Fitz; William A Truitt; Pascal Bonaventure; Janet S Carpenter; Anantha Shekhar; Philip L Johnson
Journal:  Psychoneuroendocrinology       Date:  2015-12-18       Impact factor: 4.905

8.  Sternal skin conductance: a reasonable surrogate for hot flash measurement?

Authors:  Deirdre R Pachman; Charles L Loprinzi; Paul J Novotny; Daniel V Satele; Breanna M Linquist; Sherry Wolf; Debra L Barton
Journal:  Menopause       Date:  2013-11       Impact factor: 2.953

9.  Treatment of menopausal hot flashes with 5-hydroxytryptophan.

Authors:  Robert R Freedman
Journal:  Maturitas       Date:  2009-12-23       Impact factor: 4.342

10.  A randomised controlled trial of a brief cognitive behavioural intervention for men who have hot flushes following prostate cancer treatment (MANCAN).

Authors:  Evgenia Stefanopoulou; Omar Yousaf; Elizabeth A Grunfeld; Myra S Hunter
Journal:  Psychooncology       Date:  2015-03-09       Impact factor: 3.894

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.